Octavius Plant. (542938)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 1.17 and book value of ₹62.06 offer some downside cushion relative to the ₹72.60 share price.
• P/E of 14.32 is modest if trailing earnings of roughly ₹1.6 Cr can be sustained.
• Sales growth of 199.79% shows the company is expanding its revenue base, though profitability lags.
• Trading at its 52-week high of ₹72.60 indicates recent market interest and momentum.

Concerns

• Latest quarter net profit of ₹0 Cr on ₹14 Cr sales means top-line growth is not converting to bottom-line profits.
• Profit growth of 0.00% alongside 199.79% sales growth points to severe margin compression or one-off issues.
• ROE of 6.45% and ROCE of 5.44% are weak; returns barely exceed the cost of capital.
• Piotroski F-Score of 4/9, zero dividend, and missing debt/promoter data raise red flags on financial health and transparency.

AI Analysis

At ₹72.60, Octavius Plant looks cheap at first glance: market cap ₹23 Cr, P/E 14.32, and P/B 1.17 against book value ₹62.06. But Graham taught me that price is what you pay, value is what you get. The value here is questionable. Sales jumped 199.79%, but profit growth is 0.00%, and the latest quarter shows ₹14 Cr of sales with net profit of ₹0 Cr. That is revenue without earnings—a red flag, not a growth story. Tea and coffee are commodities; without pricing power or a strong brand, a small player like this is at the mercy of input costs and market prices. ROE of 6.45% and ROCE of 5.44% are below what I expect from a durable business. There is no dividend. The Piotroski score of 4/9 confirms weak financial health. The PEG of 0.07 is misleading because it uses the sales spike, not the flat profit. At the 52-week high of ₹72.60, the market is paying up for topline excitement, not earnings quality. Book value provides some cushion, but with no debt-equity ratio or promoter holding disclosed, I cannot fully trust the balance sheet. I would wait for proof that this sales surge can turn into meaningful net profit and that management can generate returns above cost of capital. This is a tiny, commodity-like Indian business, not a compounding machine. It may be a turnaround or asset situation, but it is not yet an investment. As Buffett says, it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Octavius stays on my watchlist, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer